GH: Guardant Health, Inc. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 2,185.96
Enterprise Value ($M) 2,192.39
Book Value ($M) 158.68
Book Value / Share 1.30
Price / Book 13.78
NCAV ($M) -280.63
NCAV / Share -2.31
Price / NCAV -7.79

Profitability (mra)
Return on Invested Capital (ROIC) -0.32
Return on Assets (ROA) -0.30
Return on Equity (ROE) -7.97

Liquidity (mrq)
Quick Ratio 6.24
Current Ratio 6.54

Balance Sheet (mrq) ($M)
Current Assets 1,347.11
Assets 1,786.42
Liabilities 1,627.74
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 563.95
Operating Income -479.13
Net Income -479.45
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -324.98
Cash from Investing 840.25
Cash from Financing 477.38

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 9.18 23.12
02-09 13G/A Fmr Llc 4.50 -40.48
02-09 13G/A Capital International Investors 3.40 -49.06
01-29 13G Baillie Gifford & Co 5.24
01-25 13G/A BlackRock Inc. 8.90 97.11

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-09 10-Q Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 704,334 5,062,641 13.91
2024-03-27 640,158 529,430 120.91
2024-03-26 225,940 1,804,724 12.52
2024-03-25 209,436 1,670,547 12.54

(click for more detail)

Similar Companies
FTRE – Fortrea Holdings Inc. NTRA – Natera, Inc.


Financial data and stock pages provided by
Fintel.io